T CELL MEDIATED PATHOLOGIC RESPONSES TO MURINE MALARIA
T 细胞介导的鼠疟疾病理反应
基本信息
- 批准号:2457641
- 负责人:
- 金额:$ 7.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The proposed studies test the hypothesis that a specific T cell subset
responding to Plasmodium yoelii mediates immune responses that
downregulate protective immunity and are of no benefit to the host.
Consistent with this hypothesis, a pair of congenic mice, BALB/c and
BALB.D2.mls/a, have been identified which differ significantly in their
ability to resist infection by P. yoelii. BALB.D2.mls/a mice have a
BALB/c genetic background but are congenic for the endogenous mouse
mammary tumor virus mtv-7. The superantigen encoded by mtv-7 deletes T
cells which express T cell receptor chains Vbeta6, 7, 8.1 or 9. When
infected with P yoelii, BALB/c mice develop anemia and a significant
degree of peripheral parasitemia (up to 60%), and sometimes die of their
infection. BALB.D2.mls/a become less anemic, and have a lower peripheral
parasitemia (less than 30%) which resolves more quickly. These mice do
not die from their infection. Thus the presence of Vbeta6, 7, 8.1 and/or
9 T cells in BALB/c mice correlates with increased susceptibility to
disease. We hypothesize that these T cells could be deleterious to the
host in two ways; 1) They could preferentially secrete cytokines which
inhibit the development of protective immunity, 2) They could mediate the
destruction of red blood cell precursors through specific autoimmune
responses or through the production of cytokines which inhibit red blood
cell generation. In the experiments proposed we will confirm and extend
the observation that Vbeta-bearing T cells are deleterious to the host
using adoptive transfer and in vivo depletion studies. We will then test
the above hypotheses by analyzing cytokine production and the generation
of autoimmune responses by these T cells.
提出的研究验证了一种假设,即特定的T细胞亚群
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE C AVERY其他文献
ANNE C AVERY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE C AVERY', 18)}}的其他基金
Dual-Degree Medical Scientist Training Program for Veterinarians
兽医双学位医学科学家培训计划
- 批准号:
10642752 - 财政年份:2020
- 资助金额:
$ 7.47万 - 项目类别:
T CELL MEDIATED PATHOLOGIC RESPONSES TO MURINE MALARIA
T 细胞介导的鼠疟疾病理反应
- 批准号:
2057658 - 财政年份:1996
- 资助金额:
$ 7.47万 - 项目类别:
T CELL MEDIATED PATHOLOGIC RESPONSES TO MURINE MALARIA
T 细胞介导的鼠疟疾病理反应
- 批准号:
2671387 - 财政年份:1996
- 资助金额:
$ 7.47万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.47万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.47万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.47万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.47万 - 项目类别:
Discovery Grants Program - Individual